Results 141 to 150 of about 7,739 (261)

Les biomarqueurs dans la maladie de Fabry: relation entre Sphingosine-1 phosphate et Lyso-Gb3 [PDF]

open access: yes, 2012
Problématique : La maladie de Fabry est une maladie métabolique à stockage lysosomal. C'est une maladie héreditaire à transmission récessive qui concerne l'enzyme alpha-Galactosidase A. Le gène de l'alpha-Galactosidase A (GLA) se trouve au niveau du bras
Moro, D.
core  

Generation of human induced pluripotent stem cell line MHHi029-A from a male Fabry disease patient carrying c.959A > T mutation

open access: yesStem Cell Research
Fabry disease (FD) is a rare and inherited monogenetic disease caused by mutations in the X-chromosomal alpha-galactosidase A gene GLA concomitant with accumulation of its substrate globotriaosylceramide (Gb3) and multi-organ symptoms.
Christopher Jahn   +10 more
doaj   +1 more source

Generation of an induced pluripotent stem cell line (SMBCi022-A) from a patient with Fabry disease

open access: yesStem Cell Research
Fabry disease (FD) is a systemic disease in which globotriaosylceramide and other naturally occurring glycosphingolipid accumulate in various tissues throughout the body due to mutation of α-galactosidase A (GLA).
Zihan Li   +7 more
doaj   +1 more source

The Pharmacological Chaperone 1-Deoxygalactonojirimycin Reduces Tissue Globotriaosylceramide Levels in a Mouse Model of Fabry Disease [PDF]

open access: hybrid, 2009
Richie Khanna   +12 more
openalex   +1 more source

Globotriaosylceramide Immunostaining of Myocardium in a Patient With Fabry Disease

open access: yesCirculation Journal, 2022
Satoru, Yoshida   +5 more
openaire   +2 more sources

Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias.

open access: yesOncology research, 1998
The presence of cell surface receptor glycolipid, globotriaosylceramide (Gb3), is essential to confer susceptibility to the E. coli-derived verotoxin (VT). Our earlier studies showed that Gb3 is expressed in ovarian carcinoma cell lines. The Gb3 content of normal ovary, benign and malignant primary ovarian tumors, and their metastases have now been ...
S, Arab   +4 more
openaire   +1 more source

Do we need more intensive enzyme replacement therapy for Anderson-Fabry disease? [PDF]

open access: yes, 2009
Bašić-Jukić, Nikolina   +3 more
core   +1 more source

Role of the Shiga toxin in the Hemolytic Uremic Syndrome [PDF]

open access: yes, 2006
En los últimos años, las infecciones por Escherichia coli productor de toxina Shiga (STEC) y el desarrollo del Síndrome Urémico Hemolítico (SUH) han cobrado tal relevancia desde el punto de vista clínico y como problema de salud pública, que se considera
Boccoli, Javier   +6 more
core  

Home - About - Disclaimer - Privacy